kabutan

Alfresa Holdings Corporation(2784) Summary

2784
TSE Prime
Alfresa Holdings Corporation
2,468.0
JPY
+4.0
(+0.16%)
Jan 29, 3:30 pm JST
16.13
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.4
PBR
0.92
Yield
2.76%
Margin Trading Ratio
0.65
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,450.0 JPY 16.00 USD
Previous Close Jan 28
2,464.0 JPY 16.14 USD
High Jan 29, 9:00 am
2,481.5 JPY 16.20 USD
Low Jan 29, 9:07 am
2,423.0 JPY 15.82 USD
Volume
249,500
Trading Value
0.62B JPY 4.02M USD
VWAP
2463.02 JPY 16.1 USD
Minimum Trading Value
246,800 JPY 1,613 USD
Market Cap
0.47T JPY 3.11B USD
Number of Trades
983
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,258
1-Year High May 15, 2025
4,934
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 32,000 22,500 0.70
Jan 16, 2026 34,400 24,700 0.72
Jan 9, 2026 39,000 24,100 0.62
Dec 26, 2025 38,600 12,600 0.33
Dec 19, 2025 36,900 35,900 0.97
Company Profile
Alfresa Holdings Corporation is Japan's largest pharmaceutical wholesaler. The company was formed through the merger of Fukujin and Azwell. It also engages in pharmaceutical contract manufacturing and medical equipment sales.
Sector
Wholesale Trade
Alfresa Holdings Corporation operates in pharmaceutical wholesale, self-medication wholesale, pharmaceutical manufacturing, and healthcare-related businesses. In its core medical pharmaceutical wholesale business, the company operates nationwide, centered around Alfresa. The self-medication wholesale business handles over-the-counter drugs and health foods. In the pharmaceutical manufacturing business, Alfresa Pharma Corporation manufactures and sells pharmaceuticals and medical diagnostic reagents. The healthcare-related business operates a chain of dispensing pharmacies. As a holding company, Alfresa Holdings Corporation formulates group-wide management policies and business plans, aiming to effectively utilize management resources and continuously enhance corporate value.